Drug General Information
Drug ID
D0S4OH
Former ID
DIB000101
Drug Name
Anti-CD20 engineered toxin bodies
Synonyms
Anti-CD20 engineered toxin bodies (lymphoma); Anti-CD20 ETBs (lymphoma), Molecular Templates; Anti-CD20 engineered toxin bodies (lymphoma), Molecular Templates
Indication Lymphoma [ICD9: 202.8, 208.9; ICD10:C81-C86] Investigative [543668]
Company
Molecular Templates Inc
Target and Pathway
Target(s) B-lymphocyte antigen CD20 Target Info Modulator [543668]
KEGG Pathway Hematopoietic cell lineage
References
Ref 543668(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2628).
Ref 543668(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2628).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.